Pain Therapeutics


The 13th Annual Pain Therapeutics conference will showcase recent finding in areas such as: current targets for analgesic development, personalised medicine, the cannabinoid approach, imaging modalities, experimental models in early phase clinical development and improving clinical trial success rates. This promises to be a truly unmissable event!

KEY REASONS TO ATTEND

• Balance of clinical and pre-clinical considerations alongside therapeutic applications
• Focus on personalised medicine and translational methods aiming to develop the efficacy of drugs
• Explore the use of anti-NGFs in the treatment of pain alongside the discovery of novel targets
• Spotlight on translational mechanistic pain biomarkers
• Study the use of imaging modalities such as fMRI for pain measurement
• Network with key industry professionals and discuss the future of pain therapeutics

Quote "EIN News" and save £100

Visitors

Heads of Department, Directors, Managers, Team Leaders Researchers and Scientists from:

- Pain and inflammation target discovery
- Analgesic preclinical development
- CNS clinical trials
- Translational imaging
- Early phase CNS research
- Epigenetics in pain and inflammation
- Chronic and neuropathic pain
- Clinical trial design
- Biomarker development
- Personalised medicine
- Pain management

Exhibitors

Sponsorship and Exhibition Opportunities are available
To find out more contact Anuja Raut - Sponsorship Executive
On tel: +44 (0)20 7827 6128 or email: araut@smi-online.co.uk

Go to event website